D

DaShenLin Pharmaceutical Group Co Ltd
SSE:603233

Watchlist Manager
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
Watchlist
Price: 16.12 CNY -3.88% Market Closed
Market Cap: 18.3B CNY
Have any thoughts about
DaShenLin Pharmaceutical Group Co Ltd?
Write Note

DaShenLin Pharmaceutical Group Co Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

DaShenLin Pharmaceutical Group Co Ltd
Interest Income Expense Peer Comparison

Comparables:
603883
603939
301017
002727
A
301408

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
D
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
Interest Income Expense
-ÂĄ195.6m
CAGR 3-Years
N/A
CAGR 5-Years
-68%
CAGR 10-Years
N/A
LBX Pharmacy Chain JSC
SSE:603883
Interest Income Expense
-ÂĄ113.5m
CAGR 3-Years
-2%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
Yifeng Pharmacy Chain Co Ltd
SSE:603939
Interest Income Expense
-ÂĄ57.9m
CAGR 3-Years
-47%
CAGR 5-Years
-32%
CAGR 10-Years
N/A
ShuYu Civilian Pharmacy Corp Ltd
SZSE:301017
Interest Income Expense
-ÂĄ101m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
Interest Income Expense
-ÂĄ82.7m
CAGR 3-Years
-134%
CAGR 5-Years
-54%
CAGR 10-Years
-23%
A
Anhui Huaren Health Pharmaceutical Co Ltd
SZSE:301408
Interest Income Expense
-ÂĄ14.1m
CAGR 3-Years
-57%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is DaShenLin Pharmaceutical Group Co Ltd's Interest Income Expense?
Interest Income Expense
-195.6m CNY

Based on the financial report for Jun 30, 2024, DaShenLin Pharmaceutical Group Co Ltd's Interest Income Expense amounts to -195.6m CNY.

What is DaShenLin Pharmaceutical Group Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-68%

Over the last year, the Interest Income Expense growth was -1%.

Back to Top